Jefferies Lifts Target on Edwards Lifesciences (EW) on Positive Panel

Article Stock Quotes (1) Comments (0)

Jefferies boosted its price target on Buy-rated Edwards Lifesciences (NYSE: EW) from $92 to $100 following a positive FDA panel for Sapien Cohort label expansion.

The vote was 12 yes and 0 no on reasonable safety; 10 yes and 2 no on reasonable efficacy; and 11 yes and 0 no on favorable risk/benefit, with 1 abstention.

"The positive panel recommendation and a lack of any red flags from the FDA support expectations for a 4Q approval," the firm comments.

For an analyst ratings summary and ratings history on Edwards Lifesciences click here. For more ratings news on Edwards Lifesciences click here.

Shares of Edwards Lifesciences closed at $90.54 yesterday, with a 52 week range of $61.59-$92.30.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• Morgan Stanley Says Tesla (TSLA) 'Top Pick in U.S. Autos'
• Topeka Capital Raises Google (GOOG) Target to $999, Co. on 'Forefront of Innovation'
• Goldman Sees Blockbuster Potential for Bristol-Myers Squibb's (BMY) Nivolumab (PD-1)

Create E-mail Alert Related Categories

Analyst Comments, Analyst PT Change

Related Entities

Jefferies & Co

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?